Ignite Creation Date:
2024-05-05 @ 11:29 PM
Last Modification Date:
2024-10-26 @ 10:34 AM
Study NCT ID:
NCT01345630
Status:
TERMINATED
Last Update Posted:
2016-01-14
First Post:
2011-04-27
Brief Title:
Comparative Trial Of Maraviroc Versus EmtricitabineTenofovir Both With DarunavirRitonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1
Sponsor:
Organization:
ViiV Healthcare
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
813
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE3 |
Observational Models:
Time Perspective List:
Who Masked List: